Displaying results 37 - 48 of 158
General Hepatology
The impact of COVID - 19 on liver fibrosis progression in mexican patients with metabolic dysfunction associated steatotic liver disease: a case - control study

The impact of COVID - 19 on liver fibrosis progression in mexican patients with metabolic dysfunction associated steatotic liv...

ePosters
View
General Hepatology
Diagnosis, prognosis and sequential use of non-invasive tests in patients with MetALD

Diagnosis, prognosis and sequential use of non-invasive tests in patients with MetALD

ePosters
View
General Hepatology
Fast and robust MRI assessment of abdominal obesity and liver tissue characteristics a population-scale analysis

Fast and robust MRI assessment of abdominal obesity and liver tissue characteristics a population-scale analysis

ePosters
View
General Hepatology
Volatile organic compound metabolites in urine are associated with MASLD and fibrosis: an environmental health study

Volatile organic compound metabolites in urine are associated with MASLD and fibrosis: an environmental health study

ePosters
View
General Hepatology
Alteration feature of VCAM1 in liver tissue of MASLD condition

Alteration feature of VCAM1 in liver tissue of MASLD condition

ePosters
View
General Hepatology
Integrating multidisciplinary screening for HCV micro-elimination in populations with metabolic disorders: Findings from the LIVE(RO)2 Project in Romania

Integrating multidisciplinary screening for HCV micro-elimination in populations with metabolic disorders: Findings from the L...

ePosters
View
General Hepatology
Statin, but not aspirin use is inversely associated with steatotic liver disease and increased liver stiffness: Results from two large prospective population based studies

Statin, but not aspirin use is inversely associated with steatotic liver disease and increased liver stiffness: Results from t...

ePosters
View
General Hepatology
Prevalence of low ceruloplasmin in patients with alcohol use disorder

Prevalence of low ceruloplasmin in patients with alcohol use disorder

ePosters
View
General Hepatology
Muscle composition predicts adverse outcomes in chronic liver disease: A 5-year follow-up study

Muscle composition predicts adverse outcomes in chronic liver disease: A 5-year follow-up study

ePosters
View
General Hepatology
ASAP score for HCC risk stratification in patients with metabolic dysfunction-associated steatotic liver disease on long-term follow-up

ASAP score for HCC risk stratification in patients with metabolic dysfunction-associated steatotic liver disease on long-term ...

ePosters
View
General Hepatology
Association between polycystic ovary syndrome, steatotic liver disease in pregnancy, and adverse pregnancy outcomes: results from the prospective Fatty Liver in Pregnancy cohort

Association between polycystic ovary syndrome, steatotic liver disease in pregnancy, and adverse pregnancy outcomes: results f...

ePosters
View
General Hepatology
Exposure to the environmental Bisphenol A influences trained immunity-related pathways in metabolic dysfunction-associated steatotic liver disease (MASLD): A preliminary observation

Exposure to the environmental Bisphenol A influences trained immunity-related pathways in metabolic dysfunction-associated ste...

ePosters
View